A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)

Montefiore Medical Center, The Bronx

Nathan Kline Institute, Orangeburg

UPMC Western Psychiatric Institute and Clinic, Pittsburgh

Ist. G. Gaslini, Genoa

Istituto Scientifico Medea, Bosisio Parini (LC)

Hospital General Universitario Gregorio Marañon, Madrid

APG- Advanced Psychiatric Group, Orlando

Vanderbilt Medical Center, Nashville

Ohio State University, Columbus

University Hospitals, Cleveland

Rush University Medical Center, Chicago

Southwest Autism Research and Resource Center, Phoenix

P.O. Gaspare Rodolico, Catania

Yale University / Yale-New Haven Hospital, New Haven

University of Minnesota, Minneapolis

Okanagan Clinical Trials, Kelowna

Janeway Childrens Health, St. John's

Holland Bloorview Kids Rehabilitation Hospital, East York

London Health Sciences Centre, London

IGAIN (Instituto Global de Atención Integral al Neurodesarrollo), Barcelona

Hospital Universitari Vall d'Hebron, Barcelona